GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $143.51 $159.34 Monday, 22nd Apr 2024 ALNY stock ended at $145.79. This is 0.96% more than the trading day before Friday, 19th Apr 2024. During the day the stock fluctuated 2.90% from a day low at $143.69 to a day high of $147.86.
90 days $143.51 $191.72
52 weeks $143.51 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
Sep 20, 2021 $187.97 $188.16 $181.96 $183.46 572 593
Sep 17, 2021 $190.43 $191.85 $185.41 $190.34 1 187 034
Sep 16, 2021 $189.10 $191.86 $185.97 $190.20 320 574
Sep 15, 2021 $187.47 $190.00 $186.24 $187.48 417 524
Sep 14, 2021 $185.32 $189.87 $184.71 $187.97 401 741
Sep 13, 2021 $190.55 $190.55 $183.00 $185.79 495 721
Sep 10, 2021 $190.42 $192.44 $188.43 $189.55 374 467
Sep 09, 2021 $187.00 $190.16 $186.91 $189.60 335 476
Sep 08, 2021 $186.65 $188.88 $184.21 $186.31 320 567
Sep 07, 2021 $197.68 $197.68 $188.01 $188.27 623 657
Sep 03, 2021 $199.67 $200.42 $197.36 $197.46 321 032
Sep 02, 2021 $198.99 $202.77 $197.03 $200.18 540 805
Sep 01, 2021 $200.72 $201.68 $196.56 $197.04 439 640
Aug 31, 2021 $204.45 $205.69 $200.33 $201.43 801 353
Aug 30, 2021 $204.80 $208.32 $203.11 $203.51 467 308
Aug 27, 2021 $202.09 $208.55 $201.96 $203.93 376 820
Aug 26, 2021 $205.07 $207.25 $202.38 $202.39 335 778
Aug 25, 2021 $201.18 $205.39 $198.70 $204.92 365 211
Aug 24, 2021 $199.01 $202.58 $196.08 $201.90 298 612
Aug 23, 2021 $198.72 $201.49 $196.60 $198.40 900 069
Aug 20, 2021 $198.43 $201.32 $196.12 $197.78 973 213
Aug 19, 2021 $196.44 $201.00 $195.00 $196.99 379 568
Aug 18, 2021 $201.77 $201.77 $197.51 $197.53 475 072
Aug 17, 2021 $195.71 $202.34 $193.85 $200.25 578 343
Aug 16, 2021 $196.30 $198.71 $193.35 $196.78 659 476
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT